US FDA proposes bringing PMTA deadline significantly forward

The US Food and Drug Administration (FDA) has suggested that the deadline for the submission of PMTA applications could be significantly advanced from the current deadline.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us